Affordable Access

Publisher Website

Glucose-lowering therapy after myocardial infarction: more questions than answers.

Authors
Type
Published Article
Journal
European heart journal
Publication Date
Volume
29
Issue
2
Pages
141–143
Identifiers
DOI: 10.1093/eurheartj/ehm595
PMID: 18199566
Source
Medline

Abstract

This editorial refers to The impact of glucose-lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial by L.G. Mellbin et al., on page 166 and Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report from the Euro Heart Survey on Diabetes and the Heart by M. Alselmino et al., on page 177

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments
F